Abstract Book - PDF - San Antonio Breast Cancer Symposium

CTRC-AACR San Antonio Breast Cancer Symposium
P4-01-12 Compliance with Recommended Follow-Up after MRI-
Guided Core Needle Biopsy of Suspicious Breast Lesions: A
Retrospective Study
Thompson MO, Lipson JA, Daniel BL, Harrigal CL, Mullarkey PJ, Ikeda
DM. Stanford University School of Medicine, Stanford, CA.
P4-01-13 Practice patterns of MRI utilization for breast cancer treatment
within the University of California system as part of the
Athena initiative
Tokin CA, Ojeda H, Mayadev JS, Hylton NM, Fowble BL, Rugo HS,
Hwang S, Hurvitz S, Wells C, Blair SL. University of California, San
Diego; University of California, Davis; University of California, San
Francisco; Duke University; University of California, Los Angeles.
P4-01-14 Can MRI predict the response to neoadjuvant chemotherapy
in breast cancer accurately?
Fatayer H, Kim B, Dall B, Sharma N, Manuel D, Shabaan A, Perren
T, Velikova G, Horgan K, Lansdown M. Leeds General Infirmary; St
James‘s University Hospital.
P4-01-15 Impact of Preoperative MRI on the Surgical Treatment of
Breast Cancer: A SEER-Medicare Analysis
Thorsen CM, Weiss JE, Kerlikowske K, Ozanne EM, Buist DS, Hubbard
RA, Tosteson AN, Henderson LM, Virnig BA, Goodrich ME, Onega
TL. University of California, San Francisco, CA; Dartmouth Medical
School, Lebanon, NH; University of Washington, Seattle, WA;
University of North Carolina, Chapel Hill, NC; University of Minnesota,
Minneapolis, MN.
P4-01-16 Withdrawn
P4-01-17 Ductolobular breast carcinoma and the role of preoperative
magnetic resonance imaging
Postma EL, El Sharouni MA, Verkooijen HM, Witkamp AJ, van den
Bosch MA, van Hillegersberg R, van Diest PJ. UMC Utrecht, Utrecht,
Utrecht, Netherlands.
Detection/Diagnosis: Molecular, Functional, and Novel Imaging
P4-02-01 18F-FDG PET/CT for the assessment of locoregional lymph
node involvement and radiotherapy indication in stage II-III
breast cancer treated with neoadjuvant chemotherapy
Koolen BB, Valdés Olmos RA, Vogel WV, Vrancken Peeters M-JTFD,
Rodenhuis S, Rutgers EJT, Elkhuizen PHM. Netherlands Cancer
Institute - Antoni van Leeuwenhoek Hospital, Amsterdam,
Netherlands.
P4-02-02 Comparison of 18F-FDG PET-CT and 11C-MET PET-CT for
assessment of response to neoadjuvant chemotherapy in
locally advanced breast carcinoma
Dinesh A, Ramteke VK, Chander J, Tripathi M, Mahajan S. Maulana
Azad Medical College, New Delhi, Delhi, India; Institute of Nuclear
Medicine & Allied Sciences, New Delhi, Delhi, India.
P4-02-03 FDG PET/CT for early monitoring of response to neoadjuvant
chemotherapy in breast cancer patients
Andrade W, Soares F, Lima E, Maciel MdS, Toledo C, Iyeyasu H, Cruz
M, Fanelli M. A. C. Camargo Cancer Hospital, São Paulo, SP, Brazil.
P4-02-04 Tissue oxyhemoglobin dynamics measured with functional
optical imaging immediately after starting chemotherapy
correlates with markers of cellular proliferation and
inflammation in a rat breast tumor model
Ueda S, Roblyer D, Cerussi A, Saeki T, Tromberg B. Beckman Laser
Institute, University of California, Irvine, Irvine, CA; Saitama Medical
University, Hidaka, Saitama, Japan.
P4-02-05 A novel 64Cu-liposomal PET agent (MM-DX-929) predicts
response to liposomal chemotherapeutics in preclinical breast
cancer models
Lee H, Zheng J, Gaddy D, Kirpotin D, Dunne M, Drummond D, Allen
C, Jaffray D, Hendriks B, Wickham T. Merrimack Pharmaceuticals,
Boston, MA; Princess Margaret Hospital, University Health Network,
Toronto, ON, Canada; Leslie Dan Faculty of Pharmacy, University of
Toronto, ON, Canada.
P4-02-06 Molecular imaging with trastuzumab and pertuzumab
of HER2-positive breast cancer in mice: a step towards
personalized medicine
Collin B, Oudot A, Vrigneaud J-M, Moreau M, Raguin O, Duchamp
O, Tizon X, Denat F, Varoqueaux N, Brunotte F, Fumoleau P.
Centre Georges François Leclerc, Dijon, France; Institut de Chimie
Moléculaire de l’université de Bourgogne, Dijon, France; Oncodesign,
Dijon, France; Roche France, Boulogne Billancourt, France.
P4-02-07 Early Optical Tomography Changes Predict Breast Cancer
Response to Neoadjuvant Chemotherapy
Lim EA, Gunther JE, Flexman M, Kim HK, Hibshoosh H, Kalinsky K,
Crew K, Maurer M, Taback B, Feldman S, Brown M, Refice S, Alvarez-
Cid M, Hielscher A, Hershman DL. Columbia University Medical
Center, New York, NY; Columbia University, New York, NY; Herbert
Irving Comprehensive Cancer Center, New York, NY; Mailman School
of Public Health, New York, NY.
P4-02-08 Quantitative Characterization of 3D Vasculature Spatial
Patterns Within Tumor Microenvironment of Breast Cancer
Stem Cells
Zhan M, Li F, Zhu Y, Ma J, Landua J, Wei W, Vadakkan T, Zhang M,
Dickinson M, Lewis M, Rosen J, Wong S. NCI Center for Modeling
Cancer Development, The Methodist Hospital, Houston, TX; Baylor
College of Medicine, Houston, TX.
P4-02-09 Molecular Breast Imaging: the sensitivity of breastspecific
gamma imaging (BSGI) as a diagnostic adjunct to
mammography and ultrasound in a triple assessment protocol
Weigert JM, Kieper DA, Stern LH, Böhm-Vélez M. Mandell and Blau
MDs PC, New Britain, CT; Hampton University, Hampton, VA; Thomas
Jefferson University, Methodist Division, Philadelphia, PA; Weinstein
Imaging Associates, Pittsburgh, PA.
P4-02-10 Molecular Breast Imaging: A multicenter clinical registry to
compare breast-specific gamma imaging (BSGI) and breast
MRI in the detection of breast carcinoma
Weigert JM, Kieper DA, Stern LH, Böhm-Vélez M. Hampton
University, Hampton, VA; Thomas Jefferson University, Methodist
Division, Philadelphia, PA; Mandell and Blau MDs PC, New Britain, CT;
Weinstein Imaging Associates, Pittsburgh, PA.
Detection/Diagnosis: Breast Imaging - Other Methods
P4-03-01 Distance of breast cancer from the skin influence axillary
nodal metastasis
Kim EJ, Chae BJ, Song BJ, Kwak HY, Chang EY, Kim SH, Jung SS. Seoul
St. Mary’s Hospital, The Catholic University of Korea, Seoul, Republic
of Korea.
P4-03-02 Automatic BI-RADS Diagnosis of Breast Lesions by
CAD(computer-aid diagnosis)
Kuo W-H, Chuang S-C, Yang S-H, Chen C-N, Chen A, Chang K-J.
National Taiwan University Hospital and National Taiwan University
College of Medicine, Taipei, Taiwan; Graduate Institute of Industrial
Engineering, National Taiwan University, Taipei, Taiwan.
P4-03-03 Feasibility study of a new volume navigation system-guided
breast biopsy method for incidental enhancing lesions
detected by breast contrast-enhanced magnetic resonance
imaging
Takahashi M, Jinno H, Hayashida T, Nemoto M, Tanimoto A, Kitagawa
Y. Keio University School of Medicine, Tokyo, Japan.
P4-03-04 The potential use of Optical Coherence Tomography for
intraoperative breast tumour margin width estimation
Wilson BC, Akens MK, Niu CJ. University Health Network, Ontario
Cancer Institute, Toronto, ON, Canada; Tornado Medical System,
Toronto, ON, Canada.
Cancer Res; 72(24 Suppl.) December 15, 2012 46s Cancer Research